Study: Medical robotics industry will hit $1.3B in 2016

Advances in robotic capabilities, combined with the improving economic environment for medical services delivery and payments, are driving demand for surgical, assistive and telemedicine-based robots, according to ABI Research.

A report by ABI, “Healthcare and Medical Robots,” predicts the global market for medical robotics will grow from just under $790 million in 2011 to nearly $1.3 billion in 2016, driven largely by sales of advanced surgical robots and related automated radiosurgical systems.

However, the initial cost of implementing these systems remains a barrier, particularly for smaller medical organizations. In addition, robotic systems for medical care and treatment require thorough clinical testing and trials as part of the regulatory approvals process. This can raise these products’ prices and draw out the time it takes to get them to market, according to ABI.

The market is also limited by the number of qualified medical institutions or practitioners who can utilize these devices. Smaller organizations simply may not be able to afford the up-front capital expenditure associated with robots, which can cost anywhere from tens of thousands of dollars to more than $4 million per unit, the research firm stated.

Around the web

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.